SEC Form 3 · accession 0000899243-15-007943
Wave Life Sciences, Inc. · WVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Takeshi Wada
Director
Period of report
Nov 10, 2015
Accepted (ET)
Nov 10, 2015 · 9:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631574
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 100,635 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $2.474 | holding | — | — | — | — | Mar 10, 2025 | Ordinary Shares | 14,699 | — | D |
Explanation of responses
- F1The share option vested as to 33% of the shares underlying such option on March 10, 2015 and the remaining shares vest in thirty-six equal monthly installments thereafter.